Other posts you might like:

Announcement

WE'RE HIRING: Administrative Coordinator

Now Hiring: Administrative Coordinator Downtown Toronto Who we are and What we do Life Sciences Ontario is a member-driv...
News

Life Sciences Ontario Celebrates Excellence and Innovation in Life Sciences with 2026 Awards Announcement

TORONTO, ON – January 15th, 2026 - Life Sciences Ontario (LSO) proudly announces the recipients of the 2026 LSO Awards, ...
News, Opinion

Life Sciences Ontario (LSO) welcomes Budget 2025: Building Canada Strong and the federal government’s continued investment in innovation, research, and the life sciences sector

Ontario’s life sciences sector contributes $58.1 billion to Ontario’s GDP, generates $8.8 billion in government revenue,...
Press Release

Catalyzing Ontario’s Life Sciences Economy: Read Life Sciences Ontario’s New Report

TORONTO, ON – [25 June 2025]: Life Sciences Ontario (LSO), in partnership with Shift Health, has just released a new rep...
March 4, 2021
News, Opinion

Canadians are paying the price for failed drug-pricing policy

Dr. Jason Field’s separates facts from fiction in a constructive www.healthydebate.ca article (https://healthydebate.ca/opinions/failed-drug-pricing-policy/). When other countries were working collaboratively with the life sciences sector as soon as #COVID hit, Health Canada was imposing drastic and uncertain price controls. Myths are separated from facts on key issues, including

  • How much Canadians actually spend on pharmaceuticals
  • The link between private sector R&D decisions and price regulations
  • The unfortunate consequence of the #PMPRB changes already: fewer and delayed new medicines that Canadians need.

Join the debate at https://healthydebate.ca/opinions/failed-drug-pricing-policy/ and if you want to share our views on the #PMPRB changes, visit LSO’s Take Action Now webpage where you can engage on Twitter and through an email to your Member of Parliament:     

Author: ElizabethVoss